Rheumatologic Manifestations of Sarcoidosis

ABSTRACT

Sarcoidosis is a systemic, clinically heterogeneous disease characterized by the development of granulomas. Any organ system can be involved, and patients may present with any number of rheumatologic symptoms. There are no U.S. Food and Drug Administration–approved therapies for the treatment of sarcoidosis. Diagnosing sarcoidosis becomes challenging, particularly when its complications cause patients’ symptoms to mimic other conditions, including polymyositis, Sjögren syndrome, or vasculitis. This review presents an overview of the etiology of and biomarkers associated with sarcoidosis. We then provide a detailed description of the rheumatologic manifestations of sarcoidosis and present a treatment algorithm based on current clinical evidence for patients with sarcoid arthritis. The discussion will focus on characteristic findings in patients with sarcoid arthritis, osseous involvement in sarcoidosis, and sarcoid myopathy. Arthritic conditions that sometimes coexist with sarcoidosis are described as well. We present two cases of sarcoidosis with rheumatologic manifestations. Our intent is to encourage a multidisciplinary, translational approach to meet the challenges and difficulties in understanding and treating sarcoidosis.

KEYWORDS

Sarcoidosis - rheumatic diseases - arthritis - myopathy

REFERENCES

• 1 Hofmann S, Franke A, Fischer A et al.. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis.  Nat Genet. 2008;  40 1103-1106
• 2 Chen E S, Moller D R. Etiology of sarcoidosis.  Clin Chest Med. 2008;  29 365-377, vii
• 3 Smith G, Brownell I, Sanchez M, Prystowsky S. Advances in the genetics of sarcoidosis.  Clin Genet. 2008;  73 401-412
• 4 Drake W P, Newman L S. Mycobacterial antigens may be important in sarcoidosis pathogenesis.  Curr Opin Pulm Med. 2006;  12 359-363
• 5 Ezzie M E, Crouser E D. Considering an infectious etiology of sarcoidosis.  Clin Dermatol. 2007;  25 259-266
• 6 Maples C J, Counselman F L. Lupus pernio.  J Emerg Med. 2007;  33 187-189
• 7 Wilcox A, Bharadwaj P, Sharma O P. Bone sarcoidosis.  Curr Opin Rheumatol. 2000;  12 321-330
• 8 Bargagli E, Olivieri C, Penza F et al.. Rare localizations of bone sarcoidosis: two case reports and review of the literature.  Rheumatol Int. 2009 Dec. 15; 
• 9 Chatham W. Rheumatic manifestations of systemic disease: sarcoidosis.  Curr Opin Rheumatol. 2010;  22 85-90
• 10 Ugwonali O F, Parisien M, Nickerson K G, Scully B, Ristic S, Strauch R J. Osseous sarcoidosis of the hand: pathologic analysis and review of the literature.  J Hand Surg [Am]. 2005;  30 854-858
• 11 Shorr A F, Murphy F T, Kelly W F, Kaplan K J, Gilliland W R, Shapeero L G. Osseous sarcoidosis clinical, radiographic, and therapeutic observations.  J Clin Rheumatol. 1998;  4 186-192
• 12 Shorr A F, Murphy F T, Gilliland W R, Hnatiuk W. Osseous disease in patients with pulmonary sarcoidosis and musculoskeletal symptoms.  Respir Med. 2000;  94 228-232
• 13 Rúa-Figueroa I, Gantes M A, Erausquin C, Mhaidli H, Montesdeoca A. Vertebral sarcoidosis: clinical and imaging findings.  Semin Arthritis Rheum. 2002;  31 346-352
• 14 Binicier O, Sari I, Sen G et al.. Axial sarcoidosis mimicking radiographic sacroiliitis.  Rheumatol Int. 2009;  29 343-345
• 15 Moore S L, Teirstein A E. Musculoskeletal sarcoidosis: spectrum of appearances at MR imaging.  Radiographics. 2003;  23 1389-1399
• 16 Mangino D, Stover D E. Sarcoidosis presenting as metastatic bony disease: a case report and review of the literature on vertebral body sarcoidosis.  Respiration. 2004;  71 292-294
• 17 Garg S, Garg K, Altaf M, Magaldi J A. Refractory vertebral sarcoidosis responding to infliximab.  J Clin Rheumatol. 2008;  14 238-240
• 18 Kötter I, Dürk H, Saal J G. Sacroiliitis in sarcoidosis: case reports and review of the literature.  Clin Rheumatol. 1995;  14 695-700
• 19 Erb N, Cushley M J, Kassimos D G, Shave R M, Kitas G D. An assessment of back pain and the prevalence of sacroiliitis in sarcoidosis.  Chest. 2005;  127 192-196
• 20 Griep E N, van Spiegel P I, van Soesbergen R M. Sarcoidosis accompanied by pulmonary tuberculosis and complicated by sacroiliitis.  Arthritis Rheum. 1993;  36 716-721
• 21 Zisman D A, Biermann J S, Martinez F J, Devaney K O, Lynch III J P. Sarcoidosis presenting as a tumorlike muscular lesion: case report and review of the literature.  Medicine (Baltimore). 1999;  78 112-122
• 22 Moore S L, Teirstein A E, Tohme-Noun C et al.. Musculoskeletal sarcoidosis: spectrum of appearances at MR imaging.  Radiographics. 2003;  23 1389-1399
• 23 Torralba K D, Quismorio Jr F P. Sarcoidosis and the rheumatologist.  Curr Opin Rheumatol. 2009;  21 62-70
• 24 Nemoto I, Shimizu T, Fujita Y, Tateishi Y, Tsuji-Abe Y, Shimizu H. Tumour-like muscular sarcoidosis.  Clin Exp Dermatol. 2007;  32 298-300
• 25 Le Roux K, Streichenberger N, Vial C et al.. Granulomatous myositis: a clinical study of thirteen cases.  Muscle Nerve. 2007;  35 171-177
• 26 Matsui K, Adachi M, Kawasaki Y, Matsuda K, Shinohara K. Sarcoidosis acutely involving the musculoskeletal system.  Intern Med. 2007;  46 1471-1474
• 27 Fayad F, Lioté F, Berenbaum F, Orcel P, Bardin T. Muscle involvement in sarcoidosis: a retrospective and followup studies.  J Rheumatol. 2006;  33 98-103
• 28 Sève P, Zénone T, Durieu I, Pillon D, Durand D V. Muscular sarcoidosis: apropos of a case [in French].  Rev Med Interne. 1997;  18 984-988
• 29 Danon M J, Perurena O H, Ronan S, Manaligod J R. Inclusion body myositis associated with systemic sarcoidosis.  Can J Neurol Sci. 1986;  13 334-336
• 30 Vattemi G, Tonin P, Marini M et al.. Sarcoidosis and inclusion body myositis.  Rheumatology (Oxford). 2008;  47 1433-1435
• 30a Larue S, Maisonobe T, Benveniste O et al.. Distal muscle involvement in granulomatous myositis can mimic inclusion body myositis.  J Neurol Neurosurg Psychatry. 2010;  , June 20 [Epub ahead of print]
• 31 Fernandes S R, Singsen B H, Hoffman G S. Sarcoidosis and systemic vasculitis.  Semin Arthritis Rheum. 2000;  30 33-46
• 32 Stone J. Rituximab versus cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial (RAVE). American College of Rheumatology Conference; October 16–21, 2009 Philadelphia, PA; Arthritis & Rheumatism 2009 60(Suppl 10): abstract 550
• 33 Mansour M J, Al-Hashimi I, Wright J M. Coexistence of Sjögren’s syndrome and sarcoidosis: a report of five cases.  J Oral Pathol Med. 2007;  36 337-341
• 34 Rudralingam M, Nolan A, Macleod I, Greenwood M, Heath N. A case of sarcoidosis presenting with diffuse, bilateral swelling of the salivary glands.  Dent Update. 2007;  34 439-440 442
• 35 Hansen S R, Hetta A K, Omdal R. Primary Sjögren’s syndrome and sarcoidosis: coexistence more than by chance?.  Scand J Rheumatol. 2008;  37 485-486
• 36 van de Loosdrecht A, Kalk W, Bootsma H, Henselmans J M, Kraan J, Kallenberg C G. Simultaneous presentation of sarcoidosis and Sjögren’s syndrome.  Rheumatology (Oxford). 2001;  40 113-115
• 37 Bamba R, Sweiss N J, Langerman A J, Taxy J B, Blair E A. The minor salivary gland biopsy as a diagnostic tool for Sjogren syndrome.  Laryngoscope. 2009;  119 1922-1926
• 38 Stonecipher K, Perry H D, Gross R H, Kerney D L. The impact of topical cyclosporine A emulsion 0.05% on the outcomes of patients with keratoconjunctivitis sicca.  Curr Med Res Opin. 2005;  21 1057-1063
• 39 Perruquet J L, Harrington T M, Davis D E, Viozzi F J. Sarcoid arthritis in a North American Caucasian population.  J Rheumatol. 1984;  11 521-525
• 40 Pettersson T. Sarcoid and erythema nodosum arthropathies.  Best Pract Res Clin Rheumatol. 2000;  14 461-476
• 41 Spilberg I, Siltzbach L E, McEwen C. The arthritis of sarcoidosis.  Arthritis Rheum. 1969;  12 126-137
• 42 Visser H, Vos K, Zanelli E et al.. Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors.  Ann Rheum Dis. 2002;  61 499-504
• 43 Ohta H, Tazawa R, Nakamura A et al.. Acute-onset sarcoidosis with erythema nodosum and polyarthralgia (Löfgren’s syndrome) in Japan: a case report and a review of the literature.  Intern Med. 2006;  45 659-662
• 44 Sato T, Tsuru T, Hagiwara K et al.. Sarcoidosis with acute recurrent polyarthritis and hypercalcemia.  Intern Med. 2006;  45 363-368
• 45 Chu A, Ginat D, Terzakis J, Seneviratne A, Schneider K S. Chronic sarcoid arthritis presenting as an intra-articular knee mass.  J Clin Rheumatol. 2009;  15 190-192
• 46 Glennås A, Kvien T K, Melby K et al.. Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome.  Br J Rheumatol. 1995;  34 45-50
• 47 Gran J T, Bøhmer E. Acute sarcoid arthritis: a favourable outcome? A retrospective survey of 49 patients with review of the literature.  Scand J Rheumatol. 1996;  25 70-73
• 48 Grunewald J, Eklund A. Role of CD4 + T cells in sarcoidosis.  Proc Am Thorac Soc. 2007;  4 461-464
• 49 Thelier N, Assous N, Job-Deslandre C et al.. Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments.  J Rheumatol. 2008;  35 1622-1628
• 50 Neville E, Walker A N, James D G. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients.  Q J Med. 1983;  52 525-533
• 51 Pennec Y, Youinou P, Le Goff P, Boles J M, Le Menn G. Comparison of the manifestations of acute sarcoid arthritis with and without erythema nodosum. Immunopathogenic significance.  Scand J Rheumatol. 1982;  11 13-16
• 52 Anandacoomarasamy A, Peduto A, Howe G, Manolios N, Spencer D. Magnetic resonance imaging in Löfgren’s syndrome: demonstration of periarthritis.  Clin Rheumatol. 2007;  26 572-575
• 53 Kellner H, Späthling S, Herzer P. Ultrasound findings in Löfgren’s syndrome: is ankle swelling caused by arthritis, tenosynovitis or periarthritis?.  J Rheumatol. 1992;  19 38-41
• 54 Proulx A M, Zryd T W. Costochondritis: diagnosis and treatment.  Am Fam Physician. 2009;  80 617-620
• 55 Baughman R P, Iannuzzi M C. Diagnosis of sarcoidosis: when is a peek good enough?.  Chest. 2000;  117 931-932
• 56 Kaplan H, Klatskin G. Sarcoidosis, psoriasis, and gout: syndrome or coincidence?.  Yale J Biol Med. 1960;  32 335-352
• 57 Goldstein R A, Becker K L, Israel H L, Moore C F. Urate metabolism in sarcoidosis.  Arch Intern Med. 1974;  133 379-381
• 58 Longcope W T, Freiman D G. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital.  Medicine (Baltimore). 1952;  31 1-132
• 59 Healy P J, Helliwell P S. Dactylitis: pathogenesis and clinical considerations.  Curr Rheumatol Rep. 2006;  8 338-341
• 60 Rothschild B M, Pingitore C, Eaton M. Dactylitis: implications for clinical practice.  Semin Arthritis Rheum. 1998;  28 41-47
• 61 Kircik L H, Del Rosso J Q. Anti-TNF agents for the treatment of psoriasis.  J Drugs Dermatol. 2009;  8 546-559
• 62 Cuchacovich R, Espinoza C G, Virk Z, Espinoza L R. Biologic therapy (TNF-alpha antagonists)-induced psoriasis: a cytokine imbalance between TNF-alpha and IFN-alpha?.  J Clin Rheumatol. 2008;  14 353-356
• 63 Baughman R P, Lower E E. A clinical approach to the use of methotrexate for sarcoidosis.  Thorax. 1999;  54 742-746
• 64 Braun J, Rau R. An update on methotrexate.  Curr Opin Rheumatol. 2009;  21 216-223
• 65 Saag K G, Teng G G, Patkar N M American College of Rheumatology et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.  Arthritis Rheum. 2008;  59 762-784
• 66 Moravan M, Segal B M. Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil.  Neurology. 2009;  72 337-340
• 67 Agrawal S, Bhagat S, Dasgupta B. Sarcoid sacroiliitis: successful treatment with infliximab.  Ann Rheum Dis. 2009;  68 283
• 68 Santos E, Shaunak S, Renowden S A, Scolding N J. Treatment of refractory neurosarcoidosis with infliximab.  J Neurol Neurosurg Psychiatry. 2010;  81 241-246
• 69 Barnabe C, McMeekin J, Howarth A, Martin L. Successful treatment of cardiac sarcoidosis with infliximab.  J Rheumatol. 2008;  35 1686-1687
• 70 Sweiss N J, Baughman R P. Tumor necrosis factor inhibition in the treatment of refractory sarcoidosis: slaying the dragon?.  J Rheumatol. 2007;  34 2129-2131
• 71 Sweiss N J, Curran J, Baughman R P. Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts.  Clin Dermatol. 2007;  25 341-346
• 72 Sweiss N J, Hushaw L L. Biologic agents for rheumatoid arthritis: 2008 and beyond.  J Infus Nurs. 2009;  32(1 Suppl) S4-17 quiz S19-24
• 73 Sweiss N J, Welsch M J, Curran J J, Ellman M H. Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.  Arthritis Rheum. 2005;  53 788-791
• 74 Palucka A K, Blanck J P, Bennett L, Pascual V, Banchereau J. Cross-regulation of TNF and IFN-alpha in autoimmune diseases.  Proc Natl Acad Sci U S A. 2005;  102 3372-3377
• 75 Kariuki S N, Crow M K, Niewold T B. The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus.  Arthritis Rheum. 2008;  58 2818-2823
• 76 Mavragani C P, Niewold T B, Moutsopoulos N M, Pillemer S R, Wahl S M, Crow M K. Augmented interferon-alpha pathway activation in patients with Sjögren’s syndrome treated with etanercept.  Arthritis Rheum. 2007;  56 3995-4004
• 77 Doyle M K, Berggren R, Magnus J H. Interferon-induced sarcoidosis.  J Clin Rheumatol. 2006;  12 241-248
• 78 Niewold T B. Interferon alpha-induced lupus: proof of principle.  J Clin Rheumatol. 2008;  14 131-132
• 79 Belkhou A, Younsi R, El Bouchti I, El Hassani S. Rituximab as a treatment alternative in sarcoidosis.  Joint Bone Spine. 2008;  75 511-512
• 80 Kausar F, Mustafa K, Sweis G et al.. Ocrelizumab: a step forward in the evolution of B-cell therapy.  Expert Opin Biol Ther. 2009;  9 889-895